PEGLAX ORANGE

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

资料单张 资料单张 (PIL)
14-05-2017
公众评估报告 公众评估报告 (PAR)
08-06-2022

有效成分:

POLYETHYLENE GLYCOL 3350

可用日期:

NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL

ATC代码:

A06AD15

药物剂型:

POWDER FOR ORAL SOLUTION

组成:

POLYETHYLENE GLYCOL 3350 99.365 %W/W

给药途径:

PER OS

处方类型:

Not required

厂商:

BEN SHIMON FLORIS LTD, ISRAEL

治疗领域:

MACROGOL

疗效迹象:

Treatment of constipation.

授权日期:

2015-10-31

资料单张

                                PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
This medicine is dispensed without a doctor’s prescription
PEGLAX NEUTRAL
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.973% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
PEGLAX ORANGE
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.365% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise
information about the medicine. If you have additional questions,
refer to the doctor or the
pharmacist.
Use the preparation according to the instructions in the dosage
section of this leaflet.
Consult the pharmacist if you need more information. Refer to the
doctor if signs of the
ailment (symptoms) worsen or do not improve.
Peglax does not contain sugar and is therefore suitable for diabetics.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for treatment of constipation. Peglax softens
the stool by
increasing the stool water content, causes normal intestinal activity
and thus relieves
constipation.
THERAPEUTIC CLASS:
Osmotic laxative.
2. BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient (polyethylene
glycol 3350) or
to any of the other ingredients this medicine contains (for a list of
inactive
ingredients see section 6 in leaflet – “Additional
information”).
•
You suffer from an intestinal or colon disease (such as ulcerative
inflammation of
the large intestine, Crohn’s disease).
•
You suffer from abdominal pain of undetermined cause.
•
You have or suspect you may have gastrointestinal perforation.
•
You have or suspect you may have bowel obstruction.
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
•
The medicine contains polyethylene glyco
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 阿拉伯文 13-12-2022
资料单张 资料单张 希伯来文 13-12-2022

查看文件历史